- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Vaccine Could Boost Immune Attack Against Brain Tumors?
Scientists in Germany have developed a vaccine that they say provides some protection against brain tumors in mice.
The vaccine works by boosting the immune system to attack abnormal cells. The approach has not been tested on humans, but clinical trials could begin next year in Germany, say researchers.
Brain tumours are difficult to treat so more research is urgently needed to give patients better options, said a cancer charity. A team at the National Centre for Tumour Diseases in Heidelberg developed a vaccine that targets brain tumour cells.
It is based on the natural ability of some patients with brain tumours to mount an immune response against the disease - although this is not enough to stop the tumour growing. The mouse experiment showed that a vaccine may be able to boost this natural approach, the researchers said.
"We can induce an immune response that is similar to what we see in some brain tumour patients who have a natural immunity but it is not strong enough to take care of the tumour," said Prof Michael Platten. The team is applying for approval to start a human clinical trial in Germany next year.
Original report: http://bbc.in/1nOZIVy
Source: BBC News
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
